As the global health crisis caused by COVID-19 continues, InBios is hard at work developing COVID-19 diagnostics. We received FDA EUA for our molecular rRT-PCR assay, IgG ELISA kit, IgM ELISA kit, IgG rapid test and POC antigen rapid test, and we continue development of other coronavirus products. Check this page frequently for updates.
We are also ready to support developers with CoV-2 recombinants and assay development. Inquire here for more information on how we can help.